VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $581,000 | -12.6% | 25,000 | -40.1% | 0.28% | +80.3% |
| Q1 2018 | $665,000 | -4.5% | 41,750 | +24.6% | 0.16% | -0.6% |
| Q4 2017 | $696,000 | -59.8% | 33,500 | -66.5% | 0.16% | -70.5% |
| Q2 2017 | $1,730,000 | +526.8% | 100,000 | +300.0% | 0.54% | +654.9% |
| Q1 2017 | $276,000 | -95.5% | 25,000 | -94.1% | 0.07% | -97.5% |
| Q4 2016 | $6,171,000 | +1431.3% | 425,000 | +2025.0% | 2.88% | +1467.4% |
| Q2 2016 | $403,000 | -52.1% | 20,000 | -37.5% | 0.18% | -4.2% |
| Q1 2016 | $842,000 | -83.4% | 32,000 | -36.0% | 0.19% | -88.2% |
| Q4 2015 | $5,083,000 | +2035.7% | 50,000 | +4559.8% | 1.63% | +3975.0% |
| Q2 2015 | $238,000 | – | 1,073 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |